TY - JOUR T1 - Measuring PIGF speeds up pre-eclampsia diagnosis JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 132 LP - 132 DO - 10.1136/dtb.2019.000053 VL - 57 IS - 9 A2 - , Y1 - 2019/09/01 UR - http://dtb.bmj.com/content/57/9/132.abstract N2 - Review of: Duhig KE, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 2019;393:1807–18.Key learning pointsClinical diagnosis of pre-eclampsia is ambiguous and may result in repeat hospital visits and anxiety for women.Placental growth factor (PIGF) has been shown to have high sensitivity and negative predictive value for pre-eclampsia that required delivery within 14 days.The introduction of PIGF testing across 11 maternity units reduced the time to diagnosis by two days.In women presenting with suspected pre-eclampsia, testing for levels of placental growth factor (PIGF) reduced time to diagnosis of pre-eclampsia and resulted in fewer severe adverse maternal outcomes.1 This randomised controlled trial in 11 UK maternity units aimed to determine whether knowing about a woman’s level of … ER -